ArticleJournal of clinical microbiology2014
In vitro antimicrobial susceptibility of Aerococcus urinae.
Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 43 citations in OpenAlex.
- Clinical characteristics and antimicrobial susceptibility ofNew microbes and new infections · 2026Article
- Association Between Antimicrobial Susceptibility Test Results and Bacteriological Cure of Mild and Moderate Bovine Clinical Mastitis.Veterinary sciences · 2026Article
- Development of disk diffusion susceptibility test methods forJournal of clinical microbiology · 2025Article
- Article
- Macrolide Resistance in theAntibiotics (Basel, Switzerland) · 2024Article
- Emerging pathogensFuture microbiology · 2024Article
- Beyond the usual suspects: emerging uropathogens in the microbiome age.Frontiers in urology · 2023Review
- Aerococcus urinae, a rare cause of aortic root abscess: a case report.Journal of medical case reports · 2022Article
- A Case Report of Aerococcus urinae Urinary Tract Infection in an Elderly Male with Multimorbidity.Cureus · 2022Article
- Clinical and microbiological characterization of Aerococcus urinae bacteraemias at Helsinki metropolitan area, Finland.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022Article
- Validation of a Gradient Diffusion Method (Etest) for Testing of Antimicrobial Susceptibility of Aerococcus urinae to Fluoroquinolones.Journal of clinical microbiology · 2021Article
- Aerococcus Viridans: Case Report, Microbiology, and Literature Review.The American journal of case reports · 2019Review
- Mitral Valve Endocarditis with Perforation from a Urinary Source: An Unusual Case and Literature Review.Case reports in cardiology · 2019Article
- A rare case of Aerococcus urinae infective endocarditis in an atypically young male: case report and review of the literature.BMC infectious diseases · 2018Review
- Spondylodiscitis due to Aerococcus urinae and literature review.Infection · 2018Review
- Article
- Article
- Clinical Characteristics and Laboratory Identification ofInternational journal of microbiology · 2017Article
- Article
- A population-based study of aerococcal bacteraemia in the MALDI-TOF MS-era.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aerococcus urinae may cause urinary tract infections, bacteremia, and endocarditis. No standardized susceptibility test methods or interpretive criteria have been proposed for this organism. This study reports the MIC results for 128 A. urinae isolates tested by broth microdilution. The isolates had low MICs to amoxicillin, cefotaxime, ceftriaxone, doxycycline, linezolid, meropenem, penicillin, rifampin, tetracycline, trimethoprim-sulfamethoxazole, and vancomycin. However, 55% of the isolates had MICs to clindamycin of >0.25 μg/ml, 44% had MICs to erythromycin of >0.25 μg/ml, and 16% had MICs to levofloxacin of >2 μg/ml.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.